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A 70% to 80% underexpression of glial cell line–derived
neurotrophic factor family receptor alpha-1 results in
Hirschsprung’s disease and an associated enterocolitis
phenotype in a new mouse model. Enterocolitis proceeds
from goblet cell dysplasia, with mucin abnormalities, to
epithelial damage. Reduced expression of glial cell line–
derived neurotrophic factor family receptor a1 may
contribute to Hirschsprung disease susceptibility.
BACKGROUND & AIMS: RET, the receptor for the glial cell
line–derived neurotrophic factor (GDNF) family ligands, is the
most frequently mutated gene in congenital aganglionic
megacolon or Hirschsprung’s disease (HSCR). The leading
cause of mortality in HSCR is HSCR-associated enterocolitis
(HAEC), which is characterized by altered mucin composition,
mucin retention, bacterial adhesion to enterocytes, and
epithelial damage, although the order of these events is
obscure. In mice, loss of GDNF signaling leads to a severely
underdeveloped enteric nervous system and neonatally fatal
kidney agenesis, thereby precluding the use of these mice for
modeling postnatal HSCR and HAEC. Our aim was to generate
a postnatally viable mouse model for HSCR/HAEC and analyze
HAEC etiology.METHODS: GDNF family receptor alpha-1 (GFRa1) hypomor-
phic mice were generated by placing a selectable marker gene
in the sixth intron of the Gfra1 locus using gene targeting in
mouse embryonic stem cells.
RESULTS: We report that 70%–80% reduction in GDNF
co-receptor GFRa1 expression levels in mice results in HSCR
and HAEC, leading to death within the first 25 postnatal days.
These mice mirror the disease progression and histopathologic
findings in children with untreated HSCR/HAEC.
CONCLUSIONS: In GFRa1 hypomorphic mice, HAEC proceeds
from goblet cell dysplasia, with abnormal mucin production and
retention, to epithelial damage. Microbial enterocyte adherence
and tissue invasion are late events and therefore unlikely to be
the primary cause of HAEC. These results suggest that goblet
cells may be a potential target for preventative treatment and
that reduced expression of GFRa1 may contribute to HSCR
susceptibility. (Cell Mol Gastroenterol Hepatol 2019;7:655–678;
https://doi.org/10.1016/j.jcmgh.2018.12.007)
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irschsprung’s disease (HSCR, also known asHcongenital intestinal aganglionosis) is a congenital
malformation characterized by a lack of enteric ganglia in
the distal part of the gut leading to constipation, gut
§Authors share co-senior authorship.
Abbreviations used in this paper: AB, Alcian Blue; cDNA, comple-
mentary DNA; E, embryonic day; ELISA, enzyme-linked immunosor-
bent assay; ENCC, enteric neural crest-derived cell; ENS, enteric
nervous system; GDNF, glial cell line–derived neurotrophic factor;
GFRa1, glial cell line–derived neurotrophic factor family receptor
alpha-1; GI, gastrointestinal; HAEC, Hirschsprung’s disease–
associated enterocolitis; HPF, high-power field; HSCR, Hirsch-
sprung’s disease; IL, interleukin; KO, knockout; LMMP, longitudinal
muscle/myenteric plexus preparation; mRNA, messenger RNA;
NADPH, reduced nicotinamide adenine dinucleotide phosphate; P,
postnatal day; PAS, periodic acid–Schiff; PBS, phosphate-buffered
saline; PCR, polymerase chain reaction; qPCR, quantitative polymer-
ase chain reaction; RET, rearranged during transfection; TBS, Tris-
buffered saline; TNF, tumor necrosis factor; WT, wild type.
Most current article
© 2018 The Authors. Published by Elsevier Inc. on behalf of the AGA
Institute. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2352-345X
https://doi.org/10.1016/j.jcmgh.2018.12.007
656 Porokuokka et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3distention, and associated failure to thrive. The underlying
pathogenic etiology is widely accepted to be based on de-
fects in craniocaudal migration, proliferation, differentia-
tion, and survival of neuroblasts that originate from the
neural crest in the early stage of pregnancy.1,2 The preva-
lence of HSCR is 1 in 5000 live births, and the disease
generally is subdivided into short-segment and long-
segment types based on the point at which histologically
characterized aganglionosis begins. Currently, HSCR
routinely is treated by surgical removal of the aganglionic
gut segment. The most life-threatening HSCR-associated
complication is HSCR-associated enterocolitis (HAEC),
which can occur preoperatively and/or postoperatively.3
HAEC develops in approximately 30% of patients with
short-segment and 50% of patients with long-segment
HSRC.4,5 The incidence of HAEC suggests either a multi-
genic and/or environmental contribution,4,6 but the patho-
genesis of HAEC remains poorly understood. Mucosal
barrier dysfunction as a predisposing factor is one of the
several proposed drivers for HAEC.4–6 HAEC is clinically
characterized by fever, abdominal distention, diarrhea, and
sepsis. Histopathologic features in the colon include crypt
dilatation, mucin retention, enterocyte adherence of bacte-
ria, a shift from acidic toward neutral mucin production,
epithelial damage, leukocyte infiltration, ulceration, and, in
the terminal stages, transmural necrosis and perforation.4–7
However, at least in part owing to a lack of suitable animal
models, the order in which these HAEC-associated clinical
features develop is currently poorly understood, which
has hampered advances in the treatment and prevention
of HAEC.
The most common genetic cause of HSCR is the pres-
ence of inactivating mutations in the receptor tyrosine
kinase rearranged during transfection (RET), the signaling
receptor for glial cell line–derived neurotrophic factor
(GDNF); approximately 50% of cases are familial, and
15%–35% are sporadic cases.2,8–11 In addition, at least 13
other HSCR susceptibility genes have been identified,
including GDNF, NRTN, EDNRB, EDN3, ECE1, SOX10,
PHOX2B, KIF1BP, ZEB2, TCF4, and TTF1; together, muta-
tions in these genes account for approximately 20% of
all HSCR cases.2,9,12,13 HSCR penetrance also is known to be
influenced by gene expression levels because copy number
variants of MAPK10, ZFHX1B, and SOX2 loci were associated
with HSCR in a pilot study on 67 candidate genes.12
Currently, the underlying genetic cause is unknown for
approximately half of all sporadic cases of HSCR.2,9
RET is activated upon binding with a complex
comprising GDNF and GDNF family receptor alpha-1
(GFRa1), a glycosylphosphatidylinositol-anchored protein.14
Studies using transgenic mice have shed light on how GDNF
signaling regulates the development of the enteric nervous
system (ENS). In the developing mouse gut, ENS progenitor
cells called enteric neural crest‒derived cells (ENCCs) enter
the foregut on embryonic day 9–9.5 (E9-E9.5). ENCCs
migrate rostrocaudally along the gut toward a GDNF source,
reach the proximal colon at E12, and colon colonization is
complete by E14.5.15,16 In addition to regulating ENCC
migration, GDNF signaling also controls the proliferation,differentiation, and survival of ENCCs.17–19 Mice that lack
expression of genes encoding GDNF, GFRa1, or RET have a
common phenotype that includes kidney agenesis and a lack
of enteric ganglia distal to the stomach.20–22 However, het-
erozygous Gdnf, Gfra1, or Ret null-allele mice with a reduced
gene dose have a relatively mild reduction in enteric neuron
numbers and do not develop the clinical features of child-
hood HSCR or HAEC.23 Mouse studies using knock-in or
timed conditional deletion alleles for Gfra1 or Ret support
the importance of GFRa1/RET signaling in ENS development
and survival through postnatal day 1 (P1).18,24,25 However,
animal models with defective GDNF/GFRa1/RET signaling
that phenocopy postnatal HSCR and/or HAEC are currently
not available.
Mutations in the RET gene are the most common ge-
netic cause of HSCR, however, causative mutations in
GFRa1 have not been found. Here, we report the generation
of GFRa1 hypomorphic mice with reduced expression of
Gfra1 at the endogenous locus. These mice were generated
by inserting a selectable marker gene within intron 6
of the Gfra1 gene. Homozygous GFRa1 hypomorphic
(Gfra1hypo/hypo) mice have a 70%–80% reduction in Gfra1
expression in the developing gut and kidney. Although
the kidneys develop normally, Gfra1hypo/hypo mice have
congenital features reminiscent of childhood long-segment
HSCR, with early postnatal onset of symptoms and
accompanying progressive HAEC; these mice generally die
at P7–P25. Our further analysis also suggests a possible
explanation why reduced gene expression in heterozygous
Gdnf, Gfra1, and Ret null-allele mice does not result in
HSCR, whereas a more severe reduction in Gfra1 expres-
sion in Gfra1hypo/hypo mice does lead to HSCR. In addition,
our analysis of Gfra1hypo/hypo mice has enabled us to better
define the sequence of events in the pathogenesis of HAEC.
Specifically, our results allow us to exclude bacterial
enterocyte adherence as the primary cause of HAEC in our
model, and suggest that goblet cell dysplasia is an early,
ubiquitous event that precedes the epithelial changes,
including crypt dilatation, mucin retention, and epithelial
damage. Together, these findings suggest that goblet cells
2019 Gfra1 Underexpression in HSCR and HAEC 657could be a candidate target for developing preventative
therapies for HAEC and that reduced expression of GFRa1
may represent a novel susceptibility trait for HSCR.
Results
Generation and Primary Characterization of
Gfra1hypo/hypo Mice
Insertion of a marker gene into an intron of a target gene
often interferes with expression of the target, yielding a
hypomorphic allele.26–30 We inserted a puDtk cassette31
into intron 6 of the Gfra1 gene (Figure 1A–C) and
analyzed the phenotype of homozygous (Gfra1puDtk/puDtk)
mice generated by crossing 2 heterozygous animals.
Compared with their expected Mendelian inheritance,
homozygous mice were under-represented by approxi-
mately 3- to 4-fold at the time of weaning (P18–P25);
moreover, homozygous mice developed severe abdominal
swelling, failed to thrive, showed increasing inactivity, and
other signs of discomfort. Of the 8 homozygous mice that
were monitored beginning at P15, none survived beyond
P27; because of ethical considerations, we did not proceed
with subsequent survival studies. During further experi-
ments, animals that showed obvious signs of discomfort,
including abdominal swelling, cachexia, and inactivity, were
euthanized. One or more of those signs usually became
evident by P4, with gradual progression until the end stage/
euthanasia, usually between P7 and P25. Necropsy per-
formed at P18–P25 showed marked caudal gut distention
(Figure 1D) starting between the distal ileum and the mid-
colon. Four of 8 homozygous animals analyzed at P18–P25
had acute erythema/hyperemia in the gastrointestinal (GI)
tract, indicative of acute inflammation (Figure 1D, right
panel). Upon further inspection, narrowed, contracted gut
that was distal to the distention was less flexible and stiff, a
feature commonly reported for aganglionic gut segments in
HSCR patients.
Analysis of Gfra1, Ret, and Gdnf Expression
Quantitative real-time polymerase chain reaction (PCR)
analysis performed at E13.5 showed that Gfra1 messenger
RNA (mRNA) levels were reduced by 75%–80% in the
kidneys, stomach, and duodenum of Gfra1hypo/hypo mice;
expression levels decreased further toward the colon, where
Gfra1 mRNA levels were reduced by approximately 90%
compared with control animals (Figure 1E). Ret mRNA
levels were normal in the stomach and duodenum, but
sharply decreased in the ileum of Gfra1hypo/hypo mice. In the
cecum and colon, Ret mRNA was not detectable in our
analysis (Figure 1E). This was expected because in the
developing gut Ret is expressed exclusively in ENCCs,
whereas Gfra1 is expressed both in ENCCs and in the sur-
rounding mesenchyme.16,32–34 As our parallel analysis
showed, ENCCs in Gfra1hypo/hypo mice were missing distal
from the midileum (see later).
Gdnf mRNA levels were slightly—albeit significantly—
increased throughout the GI tract, possibly reflecting
mechanistic compensation for the reduced expression of
GDNF receptors (Figure 1E). Western blot analysis showedthat the amount of GFRa1 protein in the gut segment from
the duodenum to the ileum of Gfra1hypo/hypo mice was
reduced by 75%–80% at E13.5 (Figure 1F and G). In the
cecum and colon, GFRa1 protein was not detectable in our
analysis. Kidney development in Gfra1hypo/hypo mice was
generally normal (Figure 1H and I). Given the hypomorphic
Gfra1 mRNA and protein levels measured in these mice, we
renamed the Gfra1puDtk allele the Gfra1 hypomorphic
(Gfra1hypo) allele.Homozygous Gfra1hypo/hypo Mice Have
Impaired Neuronal Progenitor Colonization and
Develop Aganglionosis and Hypertrophic Fibers
in the Colon
Mice that lack Gdnf, Gfra1, or Ret expression lack enteric
nerves distal to the stomach.20–22 Moreover, experiments in
which Gfra1 or Ret expression was deleted under temporal
control in the developing gut showed that GDNF/GFRa1/
RET signaling regulates the migration, proliferation, differ-
entiation, and survival of ENCCs, particularly in the distal
gut, in a gene dose-dependent manner.18,25 Consistent with
these findings, innervation of the stomach in Gfra1hypo/hypo
mice appeared normal at E13.5, and the number of neuronal
progenitors decreased gradually toward the distal gut
(Figure 2A). At E13.5, Gfra1hypo/hypo embryos lacked neuronal
progenitors from the midileum onward (Figure 2A). In the
developing gut, Ret is expressed exclusively in ENCCs,
whereas Gfra1 is expressed both in ENCCs and in the sur-
rounding mesenchyme.16,32–34 As shown in Figure 2A,
neuronal progenitors in the distal gut in Gfra1hypo/hypo
embryos are missing, explaining the observed craniocaudal
reduction in Gfra1mRNA and the absence of RetmRNA in the
distal gut (Figure 1E). Similar innervation defects were
observed at E15.5 (ie, 3–4 days before birth in mice)
(Figure 2F).
Heterozygous Gfra1 null-allele (Gfra1wild type [WT]/knockout
[KO]) mice, which had an approximate 50% reduction in
GFRa1 expression, had reduced enteric neuron fiber density
and defects in gut function measured ex vivo; however,
they did not have reduced numbers of enteric neurons,
and they did not develop symptoms of either HSCR
or HAEC.20,23,35 Our finding that a 70%–80% reduction in
Gfra1 expression caused long-segment HSCR suggests
a threshold effect in GFRa1-mediated downstream
signaling. In the developing gut, 2 forms of the GFRa1
protein are present—the membrane-associated glyco-
sylphosphatidylinositol-anchored form and the extracellular
soluble form; these 2 forms can function cooperatively in
mediating GDNF signaling in ENCCs.34 Because the concen-
tration of a solute decreases steeply as a function of distance
from the source, signaling via the soluble form of GFRa1 is
likely to be particularly sensitive to decreased expression. We
analyzed the concentration dependence of soluble GFRa1 on
downstream signaling in an MG87 fibroblast model system
that stably expressed both Ret and a luciferase gene that
reflected the activity of mitogen-activated protein kinases,36 a
downstream target of RET signaling. We stimulated these
cells with GDNF together with increasing concentrations of
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downstream signaling within a relatively narrow GFRa1
concentration range of 1.35–6.75 nmol/L (Figure 2B). These
results provide a possible explanation for the phenotype
differences observed between Gfra1WT/KO and Gfra1hypo/hypo
mice. In Gfra1WT/KO mice, the GFRa1 levels were within the
effective range, whereas GFRa1 levels fell below the effective
range in Gfra1hypo/hypo mice.Long-segment HSCR is defined as aganglionosis proximal
to the splenic flexure.37 Another hallmark clinical feature of
HSCR is the presence of extrinsic hypertrophic nerve fibers
in the distal colon.38–40 At E18.5, Gfra1hypo/hypo mice had
varying-length aganglionic segments proceeding from the
midcolon (long-segment HSCR) or even from the distal
ileum (total colonic aganglionosis), and they had hypertro-
phic nerve fibers in the distal colon (Figure 2C and D).
2019 Gfra1 Underexpression in HSCR and HAEC 659Because the presence of hypertrophic fibers in the colon of
HSCR patients is diagnosed postnatally, we analyzed the
colon in postnatal (P20) Gfra1hypo/hypo mice and found that
the hypertrophic fibers still were present (Figure 2E).
Gfra1hypo/hypo mice are born with a normal appearance;
however, they then develop symptoms that resemble HSCR,
including constipation, distention of the gut, and a failure
to thrive (Figure 1J and see later), with 100% penetrance
by P10. Consistent with early mortality, the genotypes in
the animal cohort were at the expected Mendelian ratios at
E18.5, but not at P10 or P15–P23 (Table 1). Immunohis-
tologic analysis of the ENS in Gfra1hypo/hypo mice at P10
using the pan-neuronal marker ubiquitin C-terminal
hydrolase L1 showed normal ganglia in the duodenum,
reduced ganglia size in the distal ileum, and absent or
rudimentary ubiquitin C-terminal hydrolase L1-positive
structures in the colon, reflecting hypertrophic fibers in
the colon (Figure 3A and B). Similar results were obtained
using the glial fibrillary acidic protein marker (Figure 3C
and D). Collectively, results presented in Figures 2 and 3
are consistent with previous results on timed deletion of
GFRa1 and RET until E18.5,18,25 and suggest that reduced
Gfra1 expression in Gfra1hypo/hypo mice causes impaired
craniocaudal colonization of the gut by enteric neuronal
progenitors, with subsequent aganglionosis of the distal
gut and the occurrence of hypertrophic nerve fibers in the
distal colon.
Hypertrophic Fibers in the Colon of Gfra1hypo/hypo
Mice Are Cholinergic
Hypertrophic nerve fibers in the distal colon of HSCR
patients are known to be cholinergic.40,41 The reduced
flexibility of the aganglionic gut segment in HSCR patients
is believed to result from excess extrinsic excitatory
cholinergic stimuli and a lack of intrinsic inhibitory
nitrergic stimuli.42,43 To examine the properties of the
myenteric plexus in Gfra1hypo/hypo mice, we stained
for acetylcholinesterase. Our analysis showed that
Gfra1hypo/hypo mice have normal cholinergic innervation in
the duodenum and proximal ileum, reduced cholinergicFigure 1. (See previous page). Generation of GFRa1 hypomo
hypomorphic allele was generated by inserting a puDtk cassette
blot analysis of EcoRV-digested genomic DNA isolated from em
homologous recombination (expected sizes: targeted, 7564 bp;
primers indicated in panel A by F and R (expected sizes: WT, 88
megacolon, constipation, and abdominal distention, and they fa
the WT mouse). The point of dilation is indicated by black arrow
obvious discomfort due to abdominal swelling, have clearly v
(white arrows) indicative of enterocolitis; representative images
E13.5 in the indicated organs measured using qPCR (N ¼ 4).
segment spanning from the duodenum to the ileum in E12.5 emb
E12.5 Gfra1 KO mice were included as a negative control); (G)
periments). (H) At P10, the kidneys in Gfra1hypo/hypo mice appea
WT and heterozygous littermates at P10 (P < .001). The slight re
an overall failure of the mice to thrive. (I) Compared with WT litter
mice. F, forward primer; R, reverse primer; EV, EcoRV site; ex
CHO, Chinese hamster ovary cells transfected with a plasmid e
as means ± SEM. *P < .05, **P < .01, and ***P < .001. Statisti
indicated otherwise.innervation in the distal ileum, a lack of cholinergic
innervation in the midcolon, and hypertrophic cholinergic
fibers in the distal colon (Figure 4A and B). Next, we
stained the myenteric plexus for reduced nicotinamide
adenine dinucleotide phosphate (NADPH) diaphorase,
a marker of nitric oxide synthase‒positive nitrergic
enteric neurons. Our analysis showed that Gfra1hypo/hypo
mice have normal numbers of NADPH-diaphorase‒positive
neurons in the duodenum, but a complete lack of NADPH-
diaphorase‒positive cells in the distal colon (Figure 4C and
D), reminiscent of the histopathologic findings in patients
with HSCR.42,43
Histopathologic Characterization of HSCR/HAEC
in Gfra1hypo/hypo Mice
Improving our understanding of the histopathologic
changes that occur in HAEC may eventually help in
developing more effective treatments. We used the histo-
pathologic grading system for HAEC developed by Tei-
telbaum et al7 to analyze Gfra1hypo/hypo mice. Teitelbaum
et al7 scored the histopathologic findings in HAEC in pa-
tients as follows: 0, no abnormalities; I, crypt dilatation
and mucin retention; II, cryptitis or 2 crypt abscesses per
high-power field; III, more than 2 crypt abscesses per high-
power field; IV, fibrinopurulent debris and mucosal
ulceration; and V, transluminal necrosis or perforation.
However, compared with patients, mice with HAEC had
milder infiltration of inflammatory cells into the crypts
(milder cryptitis and crypt abscesses),44 although the
epithelial pathologies were similar (see later); therefore,
we modified the grading system to primarily reflect
epithelial pathology (see the Materials and Methods sec-
tion). Another characteristic feature associated with HAEC
is an overproduction of mucus and the retention of mucus
in the colon, as well as a shift from producing acidic mucins
to producing neutral mucins.5,7 Mucins are produced pri-
marily by goblet cells and form a protective barrier pre-
venting bacterial enterocyte adherence.45 Goblet cell
hyperplasia46 and altered goblet cell function47 have been
reported in HSCR.rphic mice and analysis of Gfra1 expression. (A) The Gfra1
31 into intron 6 in the Gfra1 gene. (B) Representative Southern
bryonic stem cells, confirming correct targeting of Gfra1 via
WT, 10397 bp). (C) PCR-based genotyping of mice using the
bp; Gfra1puDtk/puDtk, 100 bp). (D) Gfra1hypo/hypo mice develop
il to thrive (note that the Gfra1hypo/hypo mouse is smaller than
s. At P18–P25, 50% of Gfra1hypo/hypo mice, sacrificed due to
isible acute erythema/hyperemia in the gastrointestinal tract
are shown. (E) Relative Gfra1, Gdnf, and Ret mRNA levels at
(F and G) Western blot analysis of GFRa1 protein in the gut
ryos. (F) Representative Western blot (samples obtained from
normalized average GFRa1 intensity (N ¼ 3 independent ex-
r anatomically normal. (J) Gfra1hypo/hypo mice are smaller than
duction in kidney size in the Gfra1hypo/hypo mice likely reflects
mates, kidney histology is grossly normal in P18 Gfra1hypo/hypo
6, exon 6; puDtk/puDtk, Gfra1puDtk/puDtk; KO/KO, Gfra1KO/KO;
ncoding GFP (-) or Gfra1 (þ). All summary data are presented
cal analyses were performed using the Student t test, unless
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Table 1.Distribution of Offspring Genotypes Born From
Breedings Between Gfra1wt/hypo Animals
Distribution,
number of
animals (% total)
Expected,
number of
animals (% total)
E18.5 WT 27 (25.23) 26.75 (25)
P ¼ .308 WT/hypo 59 (55.14) 53.5 (50)
Hypo/hypo 21 (19.63) 26.75 (25)
P10 WT 39 (24.38) 35.75 (25)
P ¼ .018 WT/hypo 96 (60.00) 71.5 (50)
Hypo/hypo 25 (15.63) 35.75 (25)
P15–P23 WT 37 (35.24) 26.25 (25)
P < .001 WT/hypo 60 (57.14) 52.5 (50)
Hypo/hypo 8 (7.62) 26.25 (25)
NOTE. At E18.5, Gfra1hypo/hypo mice are present at the
expected Mendelian ratio, but not at P10 (P < .05) or at
P15–P23 (P < .001), chi-square analysis.
2019 Gfra1 Underexpression in HSCR and HAEC 661Histopathologic characterization of HSCR/HAEC in
E18.5, P4, and P10 Gfra1hypo/hypo mice. Histologic
analysis of the colon in E18.5 Gfra1hypo/hypo mice showed no
overt changes compared with control mice (Figure 5A and
B). However, at P4, histologic analysis using Alcian blue
(AB), periodic acid‒Schiff (PAS), H&E, and Gram staining
showed from minimal to moderate epithelial damage
accompanied by crypt dilatation and a mucin shift from
acidic to neutral with mucus retention in the goblet cells
(Figure 5C–F, Table 2). At P10 the differences were
more advanced: slight to mild multifocal to diffuse epithelial
hyperplasia, as well as dysplasia (ie, disorganization)
accompanied by degeneration of surface colonocytes in
Gfra1hypo/hypo mice (Figures 6A and B) was observed, indi-
cating mild surface epithelial damage. In the hyperplastic
and degenerated areas of the colon, the epithelial cells grew
in disorganized, undulating rows with partly overlapping
nuclei (Figure 6B and C). In addition, the crypts in the colonFigure 2. (See previous page). Impaired enteric neuronal pro
distal gut of GFRa1 hypomorphic mice. (A) Immunohistoch
hydrolase L1 in E13.5 WT and Gfra1hypo/hypo mice whole-mount
progenitors (white arrows) beginning at the midjejunum of Gfra1
the distal and GDNF ileum onward; representative images are
activation of mitogen-activated protein kinase signaling by so
the PathDetect Elk-1 luciferase system were treated with the
replicates per experiment; N ¼ 2 experiments). (C and D) ubiqu
formed in E18.5 WT and Gfra1hypo/hypo mice from whole-mo
innervation in the midileum, an absence of innervation in the pro
arrowheads, a hallmark feature of HSCR); the white arrows indic
3–4 animals per genotype). (E) ubiquitin C-terminal hydrolase
myenteric plexus preparations showing normal innervation in
colon, and hypertrophic fibers in the colon of Gfra1hypo/hypo m
genotype). (F) The ENCC colonization of the mouse hindgut
sections immunostained with the pan-neuronal marker ubiqu
mice, showing that the enteric neuronal progenitors have rea
contrast, enteric neuronal progenitors reached the proximal ile
absent from the distal ileum, cecum, and colon. The point at
head; representative images from WT and Gfra1hypo/hypo mi
jejunum; prox, proximal.were mildly to moderately dilated with various degrees of
mucin retention (Figure 6B and C), indicating an over-
production and retention of mucus in the colon. We also
observed increased numbers of intraepithelial apoptotic cell
remnants in 5 of 8 Gfra1hypo/hypo mice, indicating a degen-
erative process (Figure 6B). Importantly, the severity of
these features varied between animals (the histopathologic
data from each animal are presented in Table 3).
At P10, goblet cell pathology was more advanced, with a
further shift in mucin production from acidic to neutral now
also accompanied by goblet cell hyperplasia in all mutant
mice. Notably, the earlier-described goblet cell pathology
appeared in all mice regardless of the extent of the afore-
mentioned epithelial pathology (Figure 6C, Table 3). More
specifically, we observed that PAS-positive goblet cells,
which are normally found in the apical and central parts of
the crypts, were present at the base of the crypts in the
Gfra1hypo/hypo colon (Figure 6B and C). On the other hand,
AB, which stains acidic mucins, showed that AB-positive
goblet cells, which are normally found at the base of
crypts, are either absent or filled with a foamy mixture of
both neutral and acidic mucins in the Gfra1hypo/hypo colon
(Figure 6B and C; Table 3). To gain insight into whether
altered goblet cell physiology in the Gfra1hypo/hypo colon
results from a deficit in the ENS in the colon and distal
intestine, or from a reduction in GFRa1 levels in fetal
mesenchyme in the whole intestine, we also analyzed
goblet cells in the duodenum at P10 using AB-PAS staining.
The number of goblet cells and the mucin profile were
unchanged in the duodenum at P10 (Figure 6F–H).
Finally, both Gram and H&E staining showed no
evidence of bacterial enterocyte adherence or microbial
infection in the Gfra1hypo/hypo colon at P10 (Table 3). Based
on our histopathologic grading system of HAEC, 3 of the 8
Gfra1hypo/hypo mice at P10 had a grade III HAEC score, 4 mice
had a grade II HAEC score, and 1 mouse had a grade I HAEC
score.
Taken together, these results suggest that a mucin shift
from acidic to neutral in goblet cells at P4 is furthergenitor colonization and hypertrophic nerve fibers in the
emistry using the pan-neuronal marker ubiquitin C-terminal
GI tract preparations. Note the reduced numbers of neuronal
hypo/hypo mice and the absence of neuronal progenitors from
shown (N ¼ 3–4 animals per genotype). (B) Dose-dependent
luble GFRa1. MG87 fibroblasts stably expressing RET and
indicated concentration of soluble GFRa1 (N ¼ 4 biological
itin C-terminal hydrolase L1 immunohistochemistry was per-
unt GI tract preparations, showing reduced and scattered
ximal colon, and hypertrophic fibers in the distal colon (white
ate neuronal somas. Representative images are shown (N ¼
L1 immunohistochemistry performed on P20 whole-mount
the duodenum, an absence of neuronal cell bodies in the
ice; representative images are shown (N ¼ 2–3 animals per
is complete by E14.5. Representative image of sagittal gut
itin C-terminal hydrolase L1 in E15.5 WT and Gfra1hypo/hypo
ched the distal colon in the WT mice (white arrowheads); in
um (white arrowheads) in E15.5 Gfra1hypo/hypo mice, but are
which aganglionosis begins is indicated by a black arrow-
ce are shown. dist, distal; duo, duodenum; ile, ileum; jej,
Figure 3. Analysis of the enteric nervous system in P10 Gfra1 hypomorphic mice. (A) Representative images of the pan-
neuronal marker ubiquitin C-terminal hydrolase L1 immunohistochemistry in coronal gut sections prepared from P10 mice.
(B) Quantification of the ganglionated plexus area (black arrowheads in A) in P10 WT and Gfra1hypo/hypo coronal gut sec-
tions; the residual staining in the Gfra1hypo/hypo mice colon reflects hypertrophic fibers or transition zone (white arrowheads
in A). P < .05 Gfra1WT/hypo vs Gfra1hypo/hypo in ileum and P < .01 WT and Gfra1WT/hypo vs Gfra1hypo/hypo in colon, N ¼ 4–5
mice per genotype. Analysis of variance and the Tukey multiple comparisons tests were used for statistical analysis. (C)
Immunostaining for the glial marker, glial fibrillary acidic protein (GFAP), in the duodenum of P10 mice is similar between
genotypes (N ¼ 3; representative images are shown). Black arrowheads indicate ganglia stained with GFAP, white ar-
rowheads mark residual staining from hypertrophic fibers of the transition zone. Reminiscent of the results obtained using
ubiquitin C-terminal hydrolase L1 at the same age (A and B) in the colon, Gfra1hypo/hypo mice have a smaller GFAP-positive
plexus area in the myenteric plexus relative to littermate controls quantified in panel D; N ¼ 4–5 animals per genotype;
P < .001, analysis of variance and the Tukey multiple comparisons test (data are presented as means ± SEM). All summary
data are presented as means ± SEM. *P < .05, **P < .01, and ***P < .001.
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and that those are generally ubiquitous early events in
Gfra1hypo/hypo mice. On the other hand, the interanimal
variations in epithelial damage, epithelial degeneration,
crypt dilatation, and mucin retention (Table 3) suggest thatthese changes may be secondary to goblet cell dysfunction
and appear later in HAEC.
Histopathologic characterization of HSCR/HAEC in
P18–P25 Gfra1hypo/hypo mice. To analyze the features of
advanced HAEC in our Gfra1hypo/hypo mice, we examined
Figure 4. The hypertrophic nerve fibers in the distal gut of GFRa1 hypomorphic mice are cholinergic. (A) Acetylcho-
linesterase histochemistry at P10 showing similar innervation in the duodenum, as well as cholinergic hypertrophic nerve fibers
characteristic of HSCR in the colon of Gfra1hypo/hypomice. In the ileum, an image distal of the point of dilatation is shown (N ¼ 3
animals per genotype). (B) Quantification of the acetylcholinesterase-positive plexus area in P10 WT and Gfra1hypo/hypo mice
(N ¼ 3 animals per genotype, ***P < .001). (C) NADPH diaphorase histochemistry for nitric oxide synthase (NOS)-positive
neurons in P10 mice showing similar innervation in the duodenum and an absence of NOS-positive innervation in the colon of
Gfra1hypo/hypo mice; N ¼ 4–5 animals per genotype (N ¼ 2 animals per genotype for the colon). (D) Quantification of NOS-
positive plexus area in P10 WT and Gfra1hypo/hypo mice; N ¼ 4–5 animals per genotype (N ¼ 2 animals per genotype for
the colon). Analysis of variance and the Tukey multiple comparisons tests were used for statistical analysis. n.a., not applicable
for Gfra1hypo/hypo mice. ACE, acetylcholinesterase; dist, distal; prox, proximal (data are presented as means ± SEM). All
summary data are presented as means ± SEM. *P < .05, **P < .01, and ***P < .001.
2019 Gfra1 Underexpression in HSCR and HAEC 663P18–P25 mice that showed obvious signs of discomfort,
including cachexia, abdominal swelling, and reduced spon-
taneous activity. In these mice, we observed histopathologic
features that are reminiscent of advanced HAEC in HSCR
patients5–7 (Figures 7 and 8; Table 4). Compared with P10
mice, in all animals analyzed the P18–P25 mice had more
advanced levels of leukocyte accumulation, epithelial dam-
age (including the presence of apoptotic cell remnants),
mucus accumulation, and crypt dilatation‒associated edema
(Figures 6–8; Tables 3 and 4). The shift from acidic toneutral mucin production observed at P10 also clearly was
evident at P18–P25 (Figure 7). Moreover, goblet cell
hyperplasia (Figure 7B and C) was present only in mice with
moderate epithelial damage; in contrast, mice with marked
epithelial damage had either degenerated goblet cells or a
combined phenotype of goblet cell hyperplasia and goblet
cell degeneration (Figures 7C and 8B; Table 4). A variety of
other features that are typical in advanced HAEC, including
ulceration, necrotic purulent colitis, crypt abscesses, and/or
the presence of focal bacterial aggregates, were observed in
Figure 5. Histopathology of colon at E18.5 and P4. (A and B) Representative H&E-stained coronal sections of the colon at
E18.5. No gross difference was observed between genotypes (N ¼ 3–4 animals per genotype). (C and D). H&E staining from
WT and Gfra1hypo/hypo colon at P4. Gfra1hypo/hypo animals typically show mild crypt dilatation accompanied with mucus
retention (D2, black bold arrow). AB-PAS staining shows more acidic mucins in WT animals at the basal crypts (C3, open
arrowhead) and more neutral mucins in Gfra1hypo/hypo animals (white arrowheads) quantified in F. **P < .01 (N ¼ 3–4). (E) The
number of goblet cells (C3 and D3, white arrows) was not changed at P4 (N ¼ 4–5). Analysis of variance and the Tukey multiple
comparisons test, data are presented as means ± SEM. All summary data are presented as means ± SEM.
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Table 2.Summary of Histopathologic Findings at P4
P4 ID
Weight,
g Sex
Applied
Teitelbaum
et al7
grade
Surface
epithelial
injury
Crypt
dilation
Intraepithelial
apoptotic
remnants
Goblet cell
hyperplasia
Mucins in crypts
Bacteria
in crypts
Enterocyte
adherence
Leukocytes
Mucin
shift to
PAS Basal Surface
Mucus
retention Granulocytes Lymphocytes
WT 7615-2 3.02 F 0 - - - No No AB PAS - - No - -
WT 7640-3 2.96 F 0 - - - No No AB PAS - - No - -
WT 7640-4 3.16 M 0 - - - No No AB PAS - - No - -
WT 7640-4a 2.92 M 0 - - - No No AB PAS - - No - -
WT/hypo 7615-4 3.15 F 0 - - - No No AB PAS - - No - þ
WT/hypo 7615-1 3.21 F 0 - - - No No AB PAS - - No - -
WT/hypo 7615-5 3.06 M 0 - - - No No AB PAS - - No - -
WT/hypo 7640-5a 2.78 M 0 - - - No No AB PAS - - No - -
Hypo/
hypo
7615-3 2.60 F I Mild þþ - No Yes PAS PAS þþ - No - -
Hypo/
hypo
7640-1 2.38 F I Mild þþ - No Yes PAS PAS þþ - No - -
Hypo/
hypo
7640-1a 2.34 M I Mild þþþ - No Yes PAS PAS þþ - No - -
Hypo/
hypo
7640-3a 2.44 M I Minimal þ - No Yes PAS PAS þþ - No - -
Hypo/
hypo
7640-2 2.51 M II Moderate þþ þ No Yes PAS PAS þþ - No - -
Minimal Mild þ Mild þ Mild þ Mild þ Normal - (<4/HPF)
0–V Mild Moderate þþ Moderate þþ Yes/no Yes/no Moderate þþ Moderate þþ Yes/no Mild þ (5–15/HPF)
Moderate Marked þþþ Marked þþþ Marked þþþ Moderate þþ (20–30/HPF)
Marked
NOTE. See the Materials and Methods section for details regarding the histopathologic grading.
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2019 Gfra1 Underexpression in HSCR and HAEC 6673 of the 4 animals investigated (Figure 7D and E). Bacterial
enterocyte adherence on the other hand was observed in
only 2 of the 3 mice with severe epithelial damage (Table 4);
these same 2 mice also had bacteria within the colon crypts
and blood vessels (Figures 7D and E and 8B and C), indi-
cating sepsis. The histopathologic findings of each mouse
examined at P4, P10, or P18–P25 are summarized in
Tables 2, 3, and 4, respectively.
Taken together, these data suggest that Gfra1hypo/hypo
animals recapitulate both the early and advanced histo-
pathologic findings present in patients with HAEC.4,5,7Characterization of Cytokine mRNA Expression
and Serum Protein Levels in Gfra1hypo/hypo Mice
A mouse long-segment HSCR/HAEC model may allow
identification of diagnostic markers and further explore the
relationship between immune response and HAEC. As a first
step in this direction we analyzed the expression of mRNAs
for Il1a, Il1b, Il1Ra, Il2, Il4, Il5, Il6, Il10, Il13, Il23, Tgfb1, Tnf,
and Ifng selected based on their presumed or hypothetical
involvement in GI tract inflammation. First, we performed a
pilot study on mRNA expression in the colon at P10, when
the HSCR/HAEC phenotype is readily detectable but less
variable than at the end stage of the disease. Of 13 selected
mRNAs, 7 were detectably expressed at P10 (Figure 9A).
Based on those preliminary results Tnf, Il1b, and Tgfb1
mRNA were selected for further analysis at E18,5, P5,
and P12–P15, while the n number of animals analyzed
at P10 was increased. We observed moderate 2- to 3-fold
up-regulation of Tnf at P5 and P10 in the colon of
Gfra1hypo/hypo animals (Figure 9B). Il1b mRNA expression
showed increased expression in Gfra1hypo/hypo mice with
remarkable interanimal variation (Figure 9C). Expression
levels of Tgfb1 were similar between genotypes
(Figure 9D). The downward trend in Tnf and Il1b mRNA
expression in older animals may reflect the fact that more
severely affected individuals die before P10 (Table 1). TheFigure 6. (See previous page).Mild epithelial damage, mucin
in P10 Gfra1hypo/hypo mice. (A1–2) H&E and AB-PAS (A3) stain
the mucosa is thin and compact with an evenly palisading, regu
white arrow) in the colon are shallow and straight. Goblet cells (A
within the proximal third of the crypts, but less abundant at the c
in the proximal parts of the crypts contain PAS-positive neutral m
cells in the basal parts of the crypts primarily contain AB-posit
head). (B and C) In Gfra1hypo/hypo mice, the colon crypts (B1, B
variable levels of mucin retention (B2, black bold arrow). The surf
in appearance (compare A1 with B1), and epithelial cells grow in
(B1, black arrow). The height variation of the epithelial cells (B2
arrowhead), increased eosinophilia in the apical cytoplasm (B2, r
arrowhead) are indicative of degeneration and mild epithelial dam
mice often are abundant in the basal parts of the crypts (C2, whit
positive (ie, neutral) mucins (compare C2 with A3). (D) Quantifi
mice, for which the number of goblet cells is increased both in
compared with both heterozygous and WT animals; N ¼ 6–8 a
have fewer AB-positive cells per crypt compared with WT colon
and hypomorphic duodenum at P10. (G) Quantification of goble
mice in P10 duodenum (N ¼ 4 per genotype). (H) Quantificatio
absent in duodenum (N ¼ 4 mice per genotype). *P < .05, **P <
Tukey multiple comparisons test, data are presented as meansobserved peak in Tnf and Il1b mRNA expression in a few
animals therefore may reflect the end stage of the disease,
which is associated with acute bacterial enterocyte attach-
ment, tissue invasion, and sepsis.
In the small intestine we were unable to detect signifi-
cant differences in Tnf and Il1bmRNA expression (Figure 9E
and F).
We also analyzed cytokine interferon g, interleukin (IL)
12, IL4, IL5, IL6, tumor necrosis factor (TNF), IL1b, and IL9
protein levels in the serum using commercially available
enzyme-linked immunosorbent assay (ELISA) analysis tools
at P10 and P14–P16. We were able to detect TNF, IL5,
and IL6 with no clear genotype–phenotype correlation
(Figure 9H and I). We hypothesized that systemic immune
activation with notable serum cytokine changes in the
Gfra1hypo/hypo HSCR/HAEC mouse model was a late event
that was associated with bacterial invasion and sepsis at the
end stage.Discussion
Here, we report that reducing GFRa1 expression in mice
does not affect renal development, but is sufficient to cause
a long-segment HSCR-like phenotype. Why is ENS develop-
ment in heterozygous Gfra1WT/KO mice grossly normal,
whereas homozygous Gfra1hypo/hypo mice, which have only a
20%–30% further reduction in GFRa1 levels compared with
Gfra1WT/KO mice, develop HSCR? Our results using a
reporter cell line suggest that GFRa1 levels need to exceed a
specific threshold before downstream signaling is activated.
It is possible that during ENS development this threshold
level of GFRa1 in Gfra1hypo/hypo mice is not reached. Previous
attempts to alter GDNF/GFRa1/RET signaling by intro-
ducing knock-in alleles for Ret led to defects in both the ENS
and kidneys.24 It is possible that the level of RET phos-
phorylation required for normal development is higher in
the developing ENS compared with the developing kidneys.
GDNF and GFRa1 also can promote synapse formation in aretention, mucin type changes, and goblet cell hyperplasia
ing of coronal colon sections from P10 WT mice. In WT mice,
lar surface epithelium. The crypts of Lieberkühn (A1 and A3,
1–3, white arrowhead) are abundant in surface epithelium and
rypt bases (A3). The goblet cells in the surface epithelium and
ucins, staining deep purple (A3, white arrowhead). The goblet
ive acidic droplets, staining light blue (A3, black open arrow-
3, and C1, white arrow) are mildly to moderately dilated, with
ace of the mucosa in the colon of Gfra1hypo/hypomice is bumpy
disorganized, undulating rows with partly overlapping nuclei
, blue bold arrow), the round to oval bland nuclei (B2, black
ed arrowheads), and the indistinct cell borders (B2, white open
age. Unlike in WT mice (A3), the goblet cells in Gfra1hypo/hypo
e arrowheads) and show a shift toward the production of PAS-
cation of goblet cells in WT, Gfra1WT/hypo, and Gfra1hypo/hypo
proximal (P < .001 and P < .01) and distal colons (P < .001)
nimals per genotype. (E) Gfra1hypo/hypo mice and Gfra1WT/hypo
(P < .001 and P < .05, N ¼ 4–5). (F) AB-PAS staining from WT
t cells (F, white arrows) in WT, Gfra1WT/hypo, and Gfra1hypo/hypo
n of PAS-positive goblet cells, AB-positive goblet cells were
.01, and ***P < .001. col, colon. Analysis of variance and the
± SEM. All summary data are presented as means ± SEM.
Table 3.Summary of Histopathologic Findings at P10
P10 ID
Weight,
g Sex
Applied
Teitelbaum
et al7
grade
Surface
epithelial
damage
Crypt
dilation
Intraepithelial
apoptotic
remnants
Goblet cell
hyperplasia
Mucins in crypts
Bacteria
in crypts
Enterocyte
adherence
Leukocytes
Mucin
shift to
PAS Basal Surface
Mucus
retention Granulocytes Lymphocytes
WT 10 6.8 F 0 - - - No No AB PAS - - No - -
WT 23 5.3 M 0 - - - No No AB PAS - - No - -
WT 6280-1 8 M 0 - - - No No AB PAS - - No - -
WT 31 4.12 M 0 - - - No No AB/PAS PAS - - No - -
WT/hypo 22 6.09 M 0 - - - No No AB/PAS PAS - - No - -
WT/hypo 24 6.42 F 0 - - - No No AB PAS - - No - -/þ
WT/hypo 6777-3 5.18 M 0 - - - No No AB PAS - - No - -
WT/hypo 6280-2 7.84 M 0 - - - No No AB PAS - - No - -
WT/hypo 12 6.42 M 0-I No/minimal - - No No AB/PAS PAS - - No - -
Hypo/
hypo
11 3.61 M I Minimal - - Yes Yes PAS PAS - - No - -
Hypo/
hypo
27 7.57 M II Mild - þ Yes Yes PAS PAS - - No - -
Hypo/
hypo
6277-7 3.6 F II Mild þ/þþ - Yes Yes PAS PAS þ - No - -
Hypo/
hypo
21 4.93 F III Moderate þ þ Yes Yes PAS PAS þþ - No - þ
Hypo/
hypo
6224-2 4.15 M II Mild þ þ Yes Yes PAS PAS þ AB þ - No - -
Hypo/
hypo
6224-7 5.93 F III Moderate þþ þ Yes Yes PAS PAS þ AB þ - No þþ -
Hypo/
hypo
7310-1 4.53 M III Moderate þþ þ Yes Yes PAS/
foamyAB
PAS/
foamyAB
þþ - No - -
Hypo/
hypo
7310-2 3.62 M II Mild þþ/þþþ - Yes Yes PAS/
foamyAB
PAS/
foamyAB
þþ - No - -
Minimal Mild þ Mild þ Mild þ Mild þ Normal - (<4/HPF)
0–V Mild Moderate
þþ
Moderate
þþ
Yes/no Yes/no Moderate
þþ
Moderate
þþ
Yes/no Mild þ (5–15/HPF)
Moderate Marked
þþþ
Marked
þþþ
Marked
þþþ
Moderate þþ (20–30/HPF)
Marked
NOTE. See the Materials and Methods section for details regarding the histopathologic grading.
668
Porokuokka
et
al
Cellular
and
M
olecular
Gastroenterology
and
Hepatology
Vol.7,No.3
2019 Gfra1 Underexpression in HSCR and HAEC 669
670 Porokuokka et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3RET-independent manner via a process called ligand-
induced cell adhesion, which also may influence cell migra-
tion,48 and therefore synapse formation could be another
process in which a reduction in GFRa1 levels may impact
ENS development differently from the kidneys.
Unfortunately, methods for quantifying RET phosphoryla-
tion in vivo are not currently available, thus precluding the
ability to quantify RET signaling to discriminate between
RET-dependent from RET-independent effects in ENS and
kidney development.
Our Gfra1hypo/hypo mouse provides an opportunity to
model childhood HSCR and HAEC arising from a defect in
the GDNF/GFRa1/RET signaling axis. At 10 days of age,
Gfra1hypo/hypo mice recapitulate the principal features of
childhood long-segment HSCR and the early features of
HAEC, including a failure to thrive, long-segment aganglio-
nosis of the colon, the presence of hypertrophic cholinergic
fibers in the distal colon, hyperplasia of goblet cells in the
colon, mucus retention, a shift from acidic to neutral mucin
production, crypt dilatation, and surface epithelial damage.
Epithelial damage included focal epithelial necrosis and
modest neutrophil infiltration, corresponding to mild cryp-
titis in human beings. Importantly, although the presence
of most of these pathologic changes varied among the
Gfra1hypo/hypo mouse colon samples at P4 and P10, 100% of
the Gfra1hypo/hypo mice at both ages had a shift from acidic to
neutral mucin production. By P10, 100% of Gfra1hypo/hypo
mice also showed similar levels of goblet cell hyperplasia,
whereas bacterial enterocyte adherence was not observed
in any mice at this age. These results suggest that goblet cell
dysfunction in the colon precedes the other pathologic
changes, and that bacterial enterocyte adherence is not an
initiating factor in HAEC. Gfra1hypo/hypo mice also provided
us with an opportunity to study whether the observedFigure 7. (See previous page). Histopathologic analysis of mo
mice. (A–C) Exacerbated mucin type changes, epithelial dama
bacterial invasion in P18–P25 Gfra1hypo/hypo mice with moderate
A2, white arrow) are relatively shallow and straight, and the su
black arrow). The goblet cells in the surface epithelium and in the
mucins, staining deep purple (A2, white arrowhead). In the basa
and the mucus in the goblet cells stain primarily with AB, staining
(goblet cells; A2, open arrowhead). In A3, gram-positive (blue to
from the surface epithelium by a layer of mucus (A3, black arrow
material and copious amounts of mucus with eosinophilic debris
were markedly dilated with retained mucin (B1–B3, white arrow)
curved black arrow) and an increased number of goblet cells
colonocytes (B2 and B3, open white arrowhead) and scattered
basal lamina propria contains moderately increased numbers
numbers of lymphocytes (C1, yellow open arrowhead), indicative
(ie, acidic) mucin (C2, black open arrowhead) in the cytoplasm
amounts of mucus (C3, black bold arrow) and a lack of bacteri
epithelial damage at the surface epithelium, crypt abscesses, b
mice with marked HAEC score. (D) In Gfra1hypo/hypo mice, cryp
filtrates in basal (D1, red open arrowheads) and apical (D2, red
shows multifocal necrotic areas and degenerative changes ac
microabscesses; D2, green arrowheads). Crypt abscesses (E1, g
enterocyte-attaching bacteria (D3 and E2, green bold arrow) also
black arrow) and a bacterial aggregate in mildly dilated crypt bas
bold arrows) and lymphocytes (E3, yellow arrowheads) are p
inflammation.altered goblet cell physiology results from the lack of the
ENS in the colon and distal parts of the small intestine or
developmental reduction in GFRa1 in the mesenchyme of
the whole fetal intestine. We found that in the duodenum of
Gfra1hypo/hypo mice both the goblet cell numbers and the
mucin profile are normal, suggesting that colonic goblet cell
hyperplasia results from the lack of ENS.
At a later age (P18–P25), all of the Gfra1hypo/hypo mice
studied showed previously known features of HAEC,
including copious mucus retention, epithelial damage in the
colon, goblet cell hyperplasia mixed with goblet cell
degeneration, and crypt dilatation and inflammation.
Importantly, enterocyte adherence and bacterial invasion
were present in only 2 of the 3 mice that had the most
advanced epithelial damage, suggesting that enterocyte
adherence and bacterial invasion are late events that mark the
end stage of the disease. Taken together, our results suggest
that HAEC may be associated with goblet cell dysfunction,
which manifests first as a shift from acidic toward neutral
mucin production in the early stage, followed by hyperplasia
and a continuous mucin shift, and mucin overproduction
during the later stages.5 Over time, these features lead to
mucus retention and crypt dilation, which in turn contribute
to progressive dysfunction of the intestinal barrier, including
progressive epithelial damage and ulceration; at the end stage
of the disease, these pathologic changes facilitate bacterial
enterocyte adherence, bacterial invasion, and, ultimately,
sepsis.6,7 Thus, our results shed light on the sequence of
events in HAEC and suggest that addressing goblet cell
dysplasia, which could remain in the proximal colon or tran-
sition zone after surgical removal of the aganglionic gut
segment, may be beneficial in treating or preventing HAEC.
Together, mutations in endothelin-related genes that
encode EDN3, EDNRB, and ECE1 account for approximatelyderate and marked HSCR/HAEC in P18–P25 Gfra1hypo/hypo
ge, scarce inflammation in the lamina propria, and a lack of
-grade HAEC. (A) In WT mice, the crypts in the colon (A1 and
rface epithelium is even and regularly palisading (A1, curved
proximal parts of the crypts contain PAS-positive (ie, neutral)
l parts of the crypts, apical mucin droplets in the colonocytes
light blue (mucin droplets; A2, yellow arrowhead) to dark blue
black) and gram-negative (intense red) bacteria are isolated
). (B) The intestinal lumens of Gfra1hypo/hypo mice contain fecal
of shed epithelial cells (B1–B3, white bold arrows). The crypts
. The surface epithelium had diffuse degeneration (B1 and B2,
(B1–B3, white arrowhead). Multifocal necrotic and apoptotic
intraepithelial neutrophils (B2, red open arrowhead). (C) The
of eosinophils (C1, black arrowhead) and mildly increased
of an inflammatory process. Note the reduction in AB-stained
of basal crypt colonocytes. Gram staining shows copious
a in mildly dilated crypts (C3, white arrow). (D and E) Marked
acterial invasion, and inflammation in P18–P25 Gfra1hypo/hypo
t dilatation (D1, white arrow) along with sparse neutrophil in-
open arrowheads) crypt epithelium. The superficial epithelium
companied by superficial dense infiltrates of neutrophils (ie,
reen arrow), dense bacterial aggregates (D3, black arrow), and
are indicated. Bacteria inside a submucosal blood vessel (E3,
e (E3, white arrow) are present. Single granulocytes (E3, yellow
resent in the lamina propria and submucosa, indicative of
Figure 8. Histopathologic analysis of HSCR/HAEC in P18–P25 Gfra1hypo/hypo mice. (A) A WT colon. (B and C)
Focal epithelial ulceration, variable colon wall changes after loss of mucosal integrity, and bacterial invasion in P18–P25
Gfra1hypo/hypo mice. Marked subepithelial edema (B1, grey arrow) and basal edema (B1, green arrow) in the lamina propria, and
copious edema in the submucosa (B1, red arrow). Vacuole formation, indicative of acute degenerative changes (B1 and B2,
yellow arrow) and mild dilatation of crypts in the colon (B1, white arrow) also are present. Copious numbers of bacteria are
attached to the surface epithelium (C1, green bold arrows). Reactive mesothelial cells (B2, green arrowheads) and thin
infiltrates of eosinophils (B2, red arrowhead), neutrophils (B2, red open arrowheads), and lymphocytes in the submucosa
(B2, yellow open arrowhead) are present. Focal marked epithelial damage with epithelial degeneration and necrosis (B3, black
arrow) are present. Subepithelial small hemorrhage (B3, blue arrow) and infiltrating neutrophils (B3, red open arrowheads) are
present. Also evident is a relative absence of AB-PAS‒positive cells (compare with panels A2 and C2 in Figure 7), which
indicate goblet cell degeneration (B4).
2019 Gfra1 Underexpression in HSCR and HAEC 6715% of all HSCR cases.1 Various animal models of HSCR with
defective endothelin signaling have been generated, and
substantial progress has been made using those models
toward understanding short-segment HSCR and HAEC. A
careful comparison between these endothelin-defective
models and our Gfra1hypo/hypo mice is an important future
objective. Such a study likely would show similarities—and
probably also differences—between the 2 genotypes and
might pave the way for the development of gene-specific
treatment strategies.
To date, more than 10 HSCR susceptibility genes have
been identified.1,2,9,11,49 However, together these genes ac-
count for approximately 50% of all HSCR cases.1,9,49 Thus,
other genetic mutations and/or traits likely underlie HSCR.
At present, neither GFRa1 protein nor GFRa1 mRNA levelsare routinely measured in colon samples resected from
HSCR patients. One study using semiquantitative PCR
reported reduced levels of GFRa1 mRNA in 3 of 13 HSCR
patients analyzed.33 Given that our results show that
reducing GFRa1 levels is sufficient to cause HSCR in mice,
measuring GFRa1 levels in a larger cohort of HSCR patients
in conjunction with epigenetic and genomic sequencing
analysis is an important future objective.Materials and Methods
Animals
Gfra1hypo mice (registered in the Mouse Genome Data-
base as the 129Ola/ICR/C57BL6-Gfra1tm1Joao mouse line)
were generated by inserting a puDtk cassette31 into intron 6
Table 4.Summary of Histopathologic Findings at P18–P25
P18–
P25 ID
Weight,
g Sex
Applied
Teitelbaum
et al7
grade
Surface
epithelial
injury
Crypt
dilation
Intraepithelial
apoptotic
remnants
Goblet cell
hyperplasia
Mucins in crypts
Bacteria
in crypts
Enterocyte
adherence
Leukocytes
Mucin shift
to PAS Basal Surface
Mucus
retention Granulocytes Lymphocytes
WT 29.12.8-9 ND ND 0 - - - No No AB PAS - - No - -
WT 23.3-9-5 11.1 F 0 - - - No No AB PAS - - No - -
WT 22.9.10CA-2 10.1 F 0 - - - No No AB PAS - - No - -
WT 5.1.9-9 12.23 M 0 - - - No No AB PAS - - No - -
WT/hypo 29.12.8-5 ND ND 0 - - - No No AB PAS - - No - þ
WT/hypo 23.3-9-6 12.1 F 0 - - - No No AB PAS - - No - -
WT/hypo 22.9.10CA-7 84 F 0 - - - No No AB PAS - - No - -
WT/hypo 22.9.10 CA-8 8.9 F 0 - - - No No AB PAS - - No - -
Hypo/
hypo
29.12.8-8 ND ND III/IV Marked þþ þþ Degenerated Yes PAS AB þ þ Yes þþ -
Hypo/
hypo
23.3-9-4 9.4 M II Moderate þþ þ Yes Yes PAS/
foamy
AB
PAS/
foamy
AB
þþ - No - þ
Hypo/
hypo
22.9.10CA-3 8.5 M III/IV Marked þ/þþ þþ Yes þ
degenerated
Degenerated degenerated Atypical
AB
þ - No þþ þ
Hypo/
hypo
22.9.10
CA-10
7.8 F II Moderate þþ/þþþ þþ Yes Yes PAS/
foamy
AB
PAS/
foamy
AB
þþ - No þ þ
Hypo/
hypo
5.1.9-7 8.8 M IV/V Marked þþ/þþþ þþþ Yes þ
degenerated
Yes PAS/
foamy
AB
PAS/
foamy
AB
þ/þþ þþ Yes þ þ
Minimal Mild þ Mild þ Mild þ Mild þ Normal - (<4/HPF)
0–V Mild Moderate
þþ
Moderate
þþ
Yes/no Yes/no Moderate
þþ
Moderate
þþ
Yes/no Mild þ (5–15/HPF)
Moderate Marked
þþþ
Marked
þþþ
Marked
þþþ
Moderate þþ (20–30/HPF)
Marked
NOTE. See the Materials and Methods section for details regarding histopathologic grading.
ND, not determined.
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recombination in embryonic stem cells (Figure 1A–C).
Embryonic stem cell clones that had undergone homologous
recombination in 1 Gfra1 allele were identified by per-
forming Southern blot analysis on EcoRV-digested genomic
DNA using the probe indicated in Figure 1A (expected sizes:
targeted, 7564 bp; WT, 10397 bp). Routine PCR-based
genotyping of the offspring was performed using the
primers indicated in Figure 1A (GfraloxF forward:
5’-cattggccaggtgaaagaca; Gfra1loxR reverse: 5’-agaaagaga
gatgatcacagtacacatg). The mice were maintained on a
129Ola/ICR/C57BL6 mixed genetic background, housed
under a 12-hour/12-hour light/dark cycle at 20C–22C, with
1 mother and litter per cage; standard chow and water were
available ad libitum. All animal experiments were approved
by the National Animal Experiment Board of Finland.
Tissue Processing
Paraffin-embedded sections, whole-mount GI tracts
(E13.5), and myenteric plexuses (P10 or P18–P25) were
used for histologic preparations. Comparable samples
obtained from the duodenum, ileum, and colon were
analyzed from all genotypes, using littermates as controls.
The samples were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 24 hours at room
temperature. Automated dehydration of the tissues and
subsequent paraffin embedding were performed using an
ASP300 S tissue processor (Leica, Wetzlar, Germany). Paraffin
blocks were cut to prepare 5-mm sections using a Tissue-Tek
microtome (Sakura, Alphen aan den Rijn, The Netherlands).
For whole-mount histology of P10 and P18–P25 tissues, the
mice were perfused intracardially with PBS and 4% para-
formaldehyde. The longitudinal muscle/myenteric plexus
(LMMP) preparations were isolated under a dissection mi-
croscope by peeling off the outer muscle layer of the GI tract
and postfixed for 15 minutes in paraformaldehyde.
Histopathology
Paraffin sections of the duodenum and colon were
stained with H&E, Gram stain, or a combination of AB (pH
2.5) and PAS using standard protocols. LMMPs from the
small and large intestine were stained for acetylcholines-
terase as previously described.50 Briefly, LMMP was washed
in PBS for 1 hour, 100 mmol/L maleic acid buffer pH 6.0 for
5 minutes, pre-incubated for 30 minutes in 65 mmol/L
maleic acid buffer including 0.5 mol/L potassium ferricya-
nide, 4 mmol/L copper sulfate, and 5 mmol/L sodium
citrate, and reacted for 30–45 minutes in 5 mmol/L ace-
tylthiocholine iodide in 100 mmol/L maleic acid buffer.Figure 9. (See previous page). Analysis of cytokine mRNA and
in the colon of Gfra1hypo/hypo and control mice at indicated ag
analysis of variance and Tukey multiple comparisons) and in P
comparisons). (E and F) Tnf and Il1b mRNA levels are not u
duodenum–jejunum was analyzed). (G–I) Measurements of serum
and control mice at the indicated ages, no significant differen
animals is given for each time point in the Figure panels (qPCR
animal; ELISA: 2 biological replicates, 1 experiment per animal).
**P < .01, and ***P < .001.NADPH diaphorase was used to visualize nitrergic neurons
in LMMPs; briefly, LMMPs were washed 2 times 1 hour in
PBS and reacted 1 hour at þ37C in a solution prepared
right before use containing 0.3% Triton (Sigma) X-100,
0.01% nitro blue tetrazolium chloride, and 0.1% NADPH in
PBS. Finally, the LMMP preparations were washed 6 times
for 5 minutes in PBS and mounted in glycerol for imaging.
Histopathology Grading
The criteria for histopathologic grading are defined later.
HAEC-associated inflammatory cell infiltration of the crypts
(cryptitis and crypt abscesses) was milder in mice than in
human beings, whereas epithelial pathology characteristic of
HAEC was recapitulated well in mice. Therefore, we modi-
fied the grading system reported by Teitelbaum et al7 to
primarily reflect epithelial pathology.
Surface epithelial damage. Epithelial damage was
graded as minimal, mild, moderate, or marked.
Minimal surface epithelial damage. The surface
epithelium consists of mild disorganization and slight
degeneration of the surface epithelium. In contrast to reg-
ular palisading, colonocytes are clustered multifocally in
disorganized, undulating rows with partially overlapping
nuclei. Apical eosinophilia and indistinct cell borders are
also visible focally.
Mild surface epithelial damage. The surface epithe-
lium has mild to moderate disorganization and mild
degenerative changes. The size and shape of the epithelial
cells and nuclei vary, and they grow in disorganized,
undulating rows with partially overlapping nuclei. Apical
cytoplasms are generally homogenously eosinophilic or
vacuolar, and the cell borders are indistinct; cells are
occasionally low columnar to cuboidal in shape. Scattered
intraepithelial apoptotic/necrotic cell remnants are present.
Moderate surface epithelial damage. The lumen of
the intestine contains copious amounts of mucus and deeply
eosinophilic debris of shed epithelial cells. The surface
epithelium has multifocal to diffuse moderate degeneration
and cuboidal to flattened cells with indistinct cell borders
and intense staining. Increased numbers of apoptotic/
necrotic cells or cell remnants are present, as well as clus-
ters of apoptotic/necrotic cells. Scattered intraepithelial
neutrophils (1–5 per high-power field [HPF]) may be pre-
sent in the lamina propria. Mildly increased numbers of
lymphocytes in the basal lamina propria (indicative of mild
chronic colitis) were detected in 1 mouse; however, in
accordance with a previous report on HAEC in mice,44
inflammatory activity is generally very low.
Marked surface epithelial damage. The surface
epithelium has generally diffuse degeneration, and multipleprotein levels. (A–D) qPCR analysis of cytokine mRNA levels
es. Tnf mRNA levels are up-regulated in P5 colon (P < .05,
10 colon (P < .05, analysis of variance and Tukey multiple
p-regulated in the small intestine (a segment spanning the
cytokine protein levels by ELISA. In analysis of Gfra1hypo/hypo
ces between the genotypes were observed. The number of
: 2–3 biological replicates, 1–2 independent experiments per
All summary data are presented as means ± SEM. *P < .05,
2019 Gfra1 Underexpression in HSCR and HAEC 675necrotic areas accompanied by small superficial infiltrates
of neutrophils (microabscesses) are present. The apical
parts of the crypts of Lieberkühn contain few to several
intraepithelial neutrophils with sporadic crypt abscesses.
The goblet cells are degenerated. The lamina propria con-
tains mildly to moderately increased numbers of eosinophils
and neutrophils in the basal areas and between the crypts.
The inflammatory reaction in the intestinal wall is mild.
Loss of integrity of the gut wall/bacterial
invasion. The surface epithelium shows gross changes of
varying degrees. The lamina propria has mild to moderate
edema and mildly to moderately increased numbers of eo-
sinophils, neutrophils, and lymphocytes. Profuse bacterial
accumulates are present in some of the moderately to
markedly dilated crypts of Lieberkühn. The submucosa has
marked edema, sparse infiltrates of leukocytes, and small
numbers of bacteria. The circular and longitudinal muscle
layers have marked diffuse degeneration and moderate
neutrophilic infiltrates. Mesothelial cells are reactive.
Crypt dilatation. Crypt dilatation was graded as minimal
to mild (þ), moderate (þþ), or marked (þþþ) to quantify
the extent of the changes. In cases in which large segmental
variation was present, both grades were reported.
Mild crypt dilatation. The dilatation is present pri-
marily at the base of the crypts, and any from a few to
approximately half of the crypts are affected.
Moderate crypt dilatation. Most of the crypts are
affected.
Marked crypt dilatation. The apical areas of the
crypts also are affected, and most of the crypts are affected.
Leukocyte numbers in the mucosa. A 3-tier system was
used to grade leukocyte numbers as minimal to mild (þ),
moderate (þþ), and marked (þþþ).
Lymphocytes. Lymphocyte number is considered to be
normal if 5 or fewer cells are generally present in the lamina
propria between the crypts per HPF. A minimal to mild in-
crease in lymphocytes is scored if they fill the intercryptal
region, and they may be increased basally below the crypt
bases. There is no increase in separation of the crypts. A
moderate increase is scored if the lymphocytes increase the
separation of the crypts; a marked increase is scored if there
is a diffuse distribution of lymphocytes with distortion of
the cryptal architecture. In accordance with a previous
report of HAEC in mice,44 none of our samples contained
moderate or marked increases in lymphocytes. Accordingly,
extremely few plasma cells were detected, and plasma cells
therefore were excluded from grading.
Granulocytes. Eosinophils and neutrophils were graded
as a single entity. Neutrophils related to surface epithelial
damage (eg, crypt abscesses, microabscesses in the epithe-
lium, and epithelial neutrophils) were omitted from this sec-
tion and were graded under surface epithelial damage.
Granulocyte number is considered to be normal if no
more than 3–4 granulocytes typically are present per HPF in
the lamina propria. A minimal to mild increase is scored if
approximately 15 granulocytes are present per HPF in the
lamina propria. A moderate increase is scored if the infil-
trate contains 20–30 granulocytes per HPF; this may be
accompanied by macrophages. A marked increase is scoredif granulocytes are the dominant population and are not
easily counted per HPF.
Quantification of Goblet Cells
Goblet cells were counted in the distal third of the colon
from the basal half of the crypts. Twenty to 30 crypts were
counted per sample. Goblet cells that primarily were stained
light blue were counted as ABþ and goblet cells stained
primarily magenta or purple were counted as PASþ. Goblet
cells fitting neither category were counted as AB-PASþ.
Sample genotypes were blinded for the counter.
Immunohistochemistry
Sections were deparaffinized through serial washes with
xylene, alcohol, and water. Antigen retrieval was performed
by boiling the samples for 10 minutes in citrate buffer
(10 mmol/L sodium citrate, 0.05% Tween 20, pH 6.0).
Endogenous peroxidase activity was quenched in 1:53 H2O2
standard solution in Tris-buffered saline (TBS) for 30 mi-
nutes at room temperature. After washing with TBS con-
taining 0.1% Tween 20, the tissue was blocked in 1.5%
normal goat serum in TBS containing 0.1% Tween 20 for
30 minutes at room temperature. The sections were incu-
bated overnight at 4C in primary antibody solution con-
taining rabbit anti-ubiquitin C-terminal hydrolase L1 (1:250,
BML-PG9500; Enzo Life Sciences) or rabbit anti–glial
fibrillary acidic protein (1:200, Ab-4 RB-087-A; Thermo-
Scientific). After washing, the sections were incubated for
90 minutes at room temperature in secondary antibody
solution containing biotinylated anti-rabbit antibody (1:200;
Vector Laboratories) or goat anti-rabbit Alexa 488 antibody
(1:400, A11034; Invitrogen). The biotinylated secondary
antibody signal was enhanced using the ABC reaction kit
(PK-4001, Vector Laboratories) and visualized using 3,30-
diaminobenzidine (SK-4100, Vector Laboratories). Samples
were dehydrated through serial washes with water, alcohol,
and xylene, and mounted using Depex (Science Services
GmbH, München, Germany). Fluorescence-labeled, whole-
mount samples were mounted in glycerol and imaged using
an Olympus BX-61 microscope. As negative controls, either
the primary or secondary antibody was omitted.
ELISA
ELISA was performed with commercial kits according to
the manufacturer’s instructions (Invitrogen ProcartaPlex
multiplex interferon g, IL12, IL4, IL5, IL6, TNF, EPX060-
20831-90, IL1B Mouse ProcartaPlex Simplex Kit, EPX01A-
26002-901, and IL9 Mouse ProcartaPlex Simplex Kit,
EPX01A-26041-901).
Quantitative PCR
RNA isolation. RNA was isolated from snap-frozen tissues
using the TRIzol reagent (Invitrogen) for samples collected
from E18.5 on or the RNAqueous Micro-kit (AM1931; Life
Technologies) in accordance with the manufacturer’s in-
structions. DNase I was supplied in the same kit.
Reverse transcription. First-strand complementary DNA
(cDNA) was synthesized from 50 to 300 ng of RNA (with
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using random hexamer primers in a final volume of 20 mL
(Transcriptor First-Strand cDNA synthesis kit; Roche). In
brief, 2 mL of random hexamer primers was mixed with
11 mL of RNA sample diluted in nuclease-free water and
incubated at 65C for 10 minutes. Next, 7 mL of a mixture
containing 4 mL of 5 reverse transcriptase buffer, 2 mL
of 100 mmol/L deoxynucleoside triphosphate, 0.5 mL of
RNase inhibitor, and 0.5 mL of Transcriptor reverse tran-
scriptase (Transcriptor First-Strand cDNA synthesis kit;
Roche) were added, mixed gently, and incubated at 25C for
10 minutes, 55C for 30 minutes, and 85C for 5 minutes. A
control sample containing no reverse transcriptase was
included in each experiment. The cDNA was cooled on ice,
diluted 1:15 in water, and either stored at -20C or used
immediately for quantitative PCR (qPCR).
Real-time qPCR. qPCR was performed using the Light-
Cycler 480 real-time PCR system (Roche Diagnostics) with
the LightCycler 480 SYBR Green I Master mix and 2.5 pmol
of primers at a final volume of 10 mL. The reactions were
run on white 384-well plates sealed with adhesive plate
sealers (04729749001; Roche Diagnostics). Each reaction
contained 2.5 mL of diluted cDNA. Each qPCR run contained
2–3 replicates of each reaction. The following qPCR program
was used: pre-incubation: 10 minutes at 95C; amplifica-
tion: 10 seconds at 95C, 15 seconds at 60C, and 15 sec-
onds at 72C for 45 cycles; melting curve: 5 seconds at 95C,
30 seconds at 55C, continuous acquisition mode at 95C
with 2 acquisitions per degree Celsius; and cooling: 10
seconds at 40C. The data were analyzed using LightCycler
480 Software Release 1.5.0 SP1, with the Absolute Quanti-
fication/2nd Derivative Max calculation. Actb was amplified
as a reference gene. The following mus musculus (m) primer
sets were used in this study: mActb: 5’-ctaaggccaaccgtgaaaag
and 5’-accagaggcatacagggaca; mGdnf ex2–3: 5’-cgctgaccagt
gactccaatatgc and 5’-tgccgcttgtttatctggtgacc; mGfra1: 5’-ttcc
cacacacgttttacca and 5’-gcccgatacattggatttca; mIfng: 5’-ttctt
cagcaacagcaaggc and 5’-tcagcagcgactccttttcc; mIl1b: 5’-agttga
cggaccccaaaag and 5’-agctggatgctctcatcagg; mIl1a: 5’-gtcgg
caaagaaatcaagatg and 5’-gtcttcgttttcactgtaacag; mIl1Ra: 5’-aa
ccagctcattgctgggtactta and 5’-gcccaagaacacactatgaaggtc; mIl2:
5’-ttgtgctccttgtcaacagc and 5’-ctggggagtttcaggttcct; mIl4: 5’-aa
cgaggtcacaggagaagg and 5’-tctgcagctccatgagaaca; mIl5: 5’-ac
cgagctctgttgacaag and 5’-tcctcgccacacttctcttt; mIl6: 5’-accac
ttcacaagtcggagg and 5’-tgcaagtgcatcatcgttgt; mIl10: 5’-ataact
gcacccacttccca and 5’-cttggcaacccaagtaaccc; mIl13: 5’-gca
gcatggtatggagtgtg and 5’-tggcgaaacagttgctttgt; mIl23: 5’-gctgt
gcctaggagtagcag and 5’-tggctgttgtccttgagtcc; mRet t2 : 5’-tccc
ttccacatggattga and 5’-atcggctctcgtgagtggta; mTgfb1: 5’-tgga
gcaacatgtggaactc and 5’-gtcagcagccggttacca; and mTnf: 5’-gatc
ggtccccaaagggatg and 5’-tgagggtctgggccatagaa.Western Blot Analysis
Snap-frozen E12.5 tissue was homogenized in a
homogenization solution containing 0.3 mol/L sucrose,
10 mmol/L HEPES, 1 mmol/L EDTA (pH 7.2–7.4), and a
proteinase inhibitor (Complete Mini-Tabs Cocktail Set;
Roche); the protein concentration was measured using theLowry method (Bio-Rad). A total of 5–10 mg of protein was
mixed with Laemmli sample buffer and incubated at 95C
for 5 minutes. The proteins were separated on an 8%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
and transferred to a nitrocellulose membrane (Amersham
Protran, GE Healthcare). After washing and blocking at
room temperature for 60 minutes in 5% milk, the mem-
branes were incubated in goat anti-Gfra1 antibody (1:1000,
GT15004; Neuromics). After washing, the membranes were
incubated at room temperature for 2 hours in horseradish
peroxidase–conjugated anti-goat antibody (1:2000, P0449;
Dako). The protein bands were visualized using enhanced
chemiluminescence substrate (Pierce). As a loading control,
the membranes then were stripped and reprobed using
anti–a-tubulin antibody (1:60,000, T9026; Sigma), followed
by horseradish peroxidase–conjugated donkey anti-mouse
antibody (1:2000, P0449; Dako). Three independent West-
ern blots were quantified with ImageJ 1.50a software (Na-
tional Institutes of Health, Bethesda, MD) and an unpaired
Student t test was performed as a statistical analysis using
GraphPad Prism software.Luciferase Assay
RET-dependent activation of mitogen-activated protein
kinase by soluble GFRa1 was measured using MG87 fibro-
blasts that stably express RET (MG87RET) and the
PathDetect-Elk1 system (219005; Stratagene). One day
before the assay, cells were plated in a 96-well plate (20,000
cells/well) in 100 mL/well Dulbecco’s modified Eagle
medium containing 10% fetal bovine serum and 100 mg/mL
normocin (ant-nr-1; InvivoGEN) and cultured overnight in
an incubator with 5% CO2. Soluble GFRa1 (1–5000 ng/mL,
560-GR; R&D Systems) and GDNF (100 ng/mL 450-10;
Peprotech) were added to wells in quadruplicate per GFRa1
concentration. The plates then were cultured for an addi-
tional 22–24 hours for luciferase expression, after which
the culture media was discarded and the cells were incu-
bated with NeoLite reagent (6016711; Perkin Elmer) for
10 minutes. Luciferase activity was measured using a
MicroBeta 2 (PerkinElmer) plate counter. Each experiment
was performed twice, and the results were analyzed using
GraphPad Prism software.References
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